短效GnRH-a用于诱发排卵预防卵巢过度刺激综合征的临床效果

中国临床药理学与治疗学 ›› 2004, Vol. 9 ›› Issue (7): 820-823.

短效GnRH-a用于诱发排卵预防卵巢过度刺激综合征的临床效果

陈晓燕, 黎平, 郭江华, 冯丽英, 李锦红

广东江门市中心医院生殖医学中心, 江门529030, 广东

收稿日期:2004-02-23 修回日期:2004-03-15 出版日期:2004-07-26 发布日期:2020-11-20
通讯作者: 陈晓燕,女,副主任医师,硕士生导师,研究方向:女性生殖内分泌疾病及不孕症的诊治。Tel:0750-3110751 E-mail:cxyan123@yahoo.com.cn

Clinical efficacy of short-effect GnRH-a for triggering ovulation on preventing ovarian hyperstimulation syndrome

CHEN Xiao-Yan, LI Ping, GUO Jiang-Hua, FENG Li-Ying, LI Jin-Hong

Reproductive Medicine Center, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China

Received:2004-02-23 Revised:2004-03-15 Online:2004-07-26 Published:2020-11-20

摘要/Abstract

摘要： 目的: 观察人绝经期促性腺激素(HMG)治疗周期中,对有可能发生卵巢过度刺激综合征(OHSS)者,使用短效促性腺激素释放激素类似物(GnRH-a)代替人绒毛膜促性腺激素(HCG)诱导排卵及预防OHSS 的效果。方法: 研究组65 例,均为用HMG 促排卵周期中出现卵巢过高反应者,卵泡成熟时使用曲普瑞林0.2mg 一次皮下注射,代替HCG 诱导排卵以预防OHSS 。排卵后肌注黄体酮40mg·d^-1支持黄体。对照组48 例,其中8 例出现卵巢过高反应中止治疗,40 例卵泡成熟时肌注HCG 5 000 ~10 000 IU 。结果: 注射曲普瑞林日血E2 水平平均3.8 ±0.9 ng·L^-1(2.9 ~ 5.8 ng·L^-1),直径≥11 mm之卵泡数平均25.4 ±8.3 个(18 ~ 35 个)。注射曲普瑞林后所有病例均有排卵,平均排卵数5.6 ±3.3 个(1 ~ 10 个),无一例出现重度OHSS 的症状及体征。18 例妊娠,妊娠率27.7 %(18 65),3 例自然流产。排卵率、妊娠率与对照组相同,无一例取消治疗周期。结论: 在未使用GnRH-a 行垂体降调节的超促排卵周期,单次足量使用短效GnRH-a 代替HCG 可有效诱导内源性LH、FSH 峰,促使卵母细胞最后成熟及排卵,同时可有效预防OHSS 的发生,对有OHSS 高危因素者,安全有效。

关键词: 促性腺激素释放激素类似物, 诱导排卵, 卵巢过度刺激综合征, 人绒毛膜促性腺激素

Abstract: AIM: To investigate the role of triggering ovulation and prevention of ovarian hyperstimulation syndrome (OHSS) by gonadotropin-releasing hormone agonist (GnRH-a) instead of human chorionic gonadotropin (HCG) in ovarian hyperresponders to human menopausal gonadotropin (HMG) treatment.METHODS: Research group involved 65 patients with high risk of developing OHSS, and they were given single dose subcutaneous injection of 0.2 mg triptorelin to trigger ovulation and prevent OHSS.Luteal support was initiated after ovulation with daily injections of 40 mg progesterone.There were 48 patients in control group, and 8 of them appeared ovarian hyperresponse to HMG and discontinued the treatment.40 patients were given HCG 5000 -10000 IU when follicles reached maturation.RESULTS: On the day of triptorelin injection the mean serum oestradiol concentration was 3.8 ±0.9 ng·L^-1 (range 2.9 -5.8 ng·L^-1)and the mean number of follicles ≥11 mm was 25.4 ±8.3 (range 18 -35).After triptorelin was administered,ovulation was effectively triggered in all of 65 patients, and the mean number of ovulation was 5.6 ±3.3 (range 1 -10).None of the patients developed signs or symptoms of severe OHSS.There were 18 (27.7 %) clinical pregnancies and 3 abortions.Ovulation rate and pregnancy rate showed no difference in comparison with control group, and none of research group discontinued the treatment.CONCLUSION: When the GnRH-a is not used before ovarian stimulation to pituitary down-regulation, adequate single dose of short-effect GnRH-a is able to effectively trigger an endogenous LH FSH surge, resulting in final oocyte maturation and ovulation, and furthermore it may effectively prevent OHSS.This strategy is special benefit to high responders with an increased risk of developing OHSS.

Key words: gonadotropin-releasing hormone agonist, triggering ovulation, ovarian hyperstimulation syndrome, Human chorionic gonadotropin

中图分类号:

R969.4

陈晓燕, 黎平, 郭江华, 冯丽英, 李锦红. 短效GnRH-a用于诱发排卵预防卵巢过度刺激综合征的临床效果[J]. 中国临床药理学与治疗学, 2004, 9(7): 820-823.

CHEN Xiao-Yan, LI Ping, GUO Jiang-Hua, FENG Li-Ying, LI Jin-Hong. Clinical efficacy of short-effect GnRH-a for triggering ovulation on preventing ovarian hyperstimulation syndrome[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(7): 820-823.

参考文献

1 Egbase PE.Severe OHSS:how many cases are preventable[J] ?Hum Reprod, 2000;15(1):8-10
2 Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, et al.Endocrine profiles after triggering of final oocyte matutation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization[J].J Clin Endocrinol Metab, 2002;87(2):709-15
3 Itskovitz-eldor J, Kol S, Mannaerts B.Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome:preliminary report:short communication[J].Hum Reprod, 2000;15(9):1965-8
4 Orvieto R.Prediction of ovarian hyperstimulation syndrome . challenging the estradiol mythos[J].Hum Reprod, 2003;18(4):665-7
5 黄宇春, 常才.多囊卵巢综合征hMG hCG 治疗临床分析[J].南通医学院学报, 1995;15:428-9
6 Gonen Y, Balakier H, Powell W, Casper RF.Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization[J].J Clin Endocrinol Metab, 1990;71(4):918-22
7 Itskovitz J, Boldes R, Levron J, Erlik Y, Kahana L, Brandes JM.Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist[J].Fertil Steril, 1991;56(2):213-20
8 Kol S, Itskovitz-eldor J.Severe OHSS:yes, there is a strategy to prevent it[J].Hum Reprod, 2000;15(11):2266-7
9 Imoedembe D, Chan R, Pacpaco E.Preventing OHSS in at-risk patients:evidence from a long-term prospective study[J].[ Abstr.no .0-185] Hum Reprod, 1999;14(1):102-3
10 evo O, Eldar-geva T, Kol S, Itskovitz-eldor J .Lower serum levels of inhibin A and pro-αC during the luteal phase after triggering oocyte maturation with gonadotropin releasing hormone (GnRH) agonist in comparison to human chorionic gonadotropin (HCG):possible relevance for the prevention of ovarian hyperstimulation (OHSS)[J].Fertil Steril, 2002;78:1001, S105

[1]	刘红丹，殷一红. 麒麟丸预防体外受精胚胎移植术后所致卵巢过度刺激综合征患者的疗效及对血浆相关指标的影响[J]. 中国临床药理学与治疗学, 2020, 25(2): 196-202.
[2]	张岭，徐维海，黄琼晓，傅晓华，张琳，李施施，朱晶，吴瑞芳，舒静. 卵巢储备功能减退患者中GnRHa扳机方案的胚胎培养结局分析[J]. 中国临床药理学与治疗学, 2019, 24(7): 799-804.
[3]	陈雅，林金菊. 低剂量人绒毛膜促性腺激素对卵巢过度刺激综合征高危患者体外受精-胚胎移植临床结局的影响[J]. 中国临床药理学与治疗学, 2016, 21(7): 811-815.
[4]	曾凡湘, 史道华, 宋一一, 孙蓬明, 郑翠仙, 邓婕, 王长连. 甲氨蝶呤治疗异位妊娠疗效预测因素分析[J]. 中国临床药理学与治疗学, 2015, 20(10): 1156-1160.
[5]	王佩玉, 余蓉, 林金菊, 肖仕全, 金聪聪, 朱如如. GnRH拮抗剂和GnRH激动剂在多囊卵巢综合征患者IVF-ET中的应用比较[J]. 中国临床药理学与治疗学, 2014, 19(7): 795-800.
[6]	颜元良, 龚志成. 卵泡刺激素受体基因多态性对女性卵巢功能影响的研究进展[J]. 中国临床药理学与治疗学, 2013, 18(8): 944-949.
[7]	胡卫华, 徐庆阳, 唐静文. 来曲唑与枸橼氯米芬对多囊卵巢综征患者诱导排卵的效果分析[J]. 中国临床药理学与治疗学, 2013, 18(7): 789-793.
[8]	盛少琴, 裘雅芬, 潘茜茜, 何吉庆. 丹参注射液对孕晚期S/D异常孕妇人绒毛膜促性腺激素水平影响及临床意义[J]. 中国临床药理学与治疗学, 2013, 18(4): 429-432.
[9]	杨海燕, 赵军招, 林文琴, 林金菊, 余蓉. 强的松及万汶对中、重度卵巢过度刺激综合征预防作用的比较[J]. 中国临床药理学与治疗学, 2011, 16(6): 652-656.